Cepheid’s Xpert™ MRSA delivers on-demand results in 58 minutes or less — 24 hours a day, 365 days a year. This reduces the window for potential transmissions from days to minutes and saves valuable bed-days when preemptive isolation is part of your infection control plan.

Runs On: GeneXpert System

It's Fast and Easy!

See how fast and easy Cepheid's Xpert MRSA test is to run:
Watch Video Now »

Problem

According to the CDC, MRSA now accounts for greater than 60% of hospital-acquired S. aureus infections in the United States (2004).

The human and financial impact of MRSA is high:

• Over 278,000 hospitalized persons are infected by MRSA annually
• 8.02 MRSA infections occur per 1,000 hospital discharges
• Over 17,000 MRSA-related hospitalizations end in death
• Excess costs of a single MRSA infection is $21,000
• Over $2.5 billion excess health care costs are attributable to MRSA infections

Solution

Guidelines on how to reduce or eliminate health-care associated infections (HAI’s) have been put forward by several organizations, including CDC, SHEA, and APIC. Each recognizes the importance of stringent policies for the care of patients infected with MRSA to minimize its spread. To significantly reduce healthcare-associated MRSA infections, it is also important to actively identify and isolate patients that may be colonized with MRSA. Cepheid’s Xpert™ MRSA is designed to provide on-demand results to optimize the effectiveness of active MRSA surveillance testing as a part of a healthcare organization’s infection control program.